Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Use of a β-Glucan Cream in Incontinence-Associated Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a beta-glucan cream for incontinence-associated dermatitis in people with fecal and urinary incontinence, and the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • β-Glucan Cream (beta-glucan cream)

Snippet

Sponsor: University of Alberta | Conditions: Fecal Incontinence, Urinary Incontinence | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING